AzTrials
AzTrials

Carotid Artery StenosisNCT05848921

Evaluation of Brain Health and Surgical Efficacy in Patients With Carotid Artery Stenosis

An observational study of Carotid Artery Stenosis and Image, run by Nanjing University of Traditional Chinese Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status. Read more about this study

Who is it for?
Ages 50 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Carotid Artery Stenosis, Image
What is being tested?
magnetic resonance image and Neuropsychological scale
Type of treatment
Medical device
How many people
100 participants
Where
1 siteChina
Study dates
1 May 2023to 31 Dec 2025
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All of the patients of carotid artery stenosis group are in-patients and out-patients in the cardiac surgery department from the research center. The subjects of control group are recruited from community.

Who may be able to join

  • Aged over 50 years old;
  • Conscious and capable of completing neuropsychological scales
  • Clinical detection of carotid artery stenosis requires surgical treatment;
  • Compliant with carotid artery stenting or carotid endarterectomy surgical standards
  • Individuals with normal cognition and mild cognitive impairment

Who cannot join

  • Degree of vascular blockage in other intracranial segments ≥ 50%
  • Have a history of mental illness, nervous system disease (such as stroke) or brain injury with loss of consciousness for more than five minutes;
  • Neurological and psychiatric disorders unrelated to AD (schizophrenia, depression, etc.), post-traumatic stress disorder, obsessive-compulsive disorder, multiple sclerosis, amyotrophic lateral sclerosis)
  • Have a history of alcohol or drug abuse
  • There are contraindications for magnetic resonance imaging examination
  • Those with significant organ dysfunction such as lung, liver, and kidney;
  • Patients with intracranial tumors, infectious diseases, and blood system diseases;
  • Participating in other clinical studies at the same time

Trial locations and contacts

1 site in 1 country.

China1 site
  • The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU

    Wenzhou, Zhejiang

    Bo Yin, phD, 0086-13857773745, 76yinbo@163.com

    Lijun Bai, phD, 0086-15129034948, bailijun@xjtu.edu.cn

Other trials in China

About this study

Official title: Research on Changes of Cerebral Vascular Morphology and Cognitive Function in Patients With Carotid Artery Stenosis Before and After Surgery

The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status. And combined with preoperative cognitive status, serum markers, and cardiovascular health evaluation indicators, evaluate and predict the possibility of postoperative neurodegenerative diseases and the level of cerebrovascular health in patients.

Read the detailed description

The aim of this study is to evaluate the brain health status and surgical efficacy of patients with carotid artery stenosis. Firstly, investigate whether hemodynamic parameters such as blood flow reserve fraction at the carotid artery stenosis site are correlated with white matter hyperintensities and cerebral vascular morphological changes in elderly patients with normal cognition and mild cognitive impairment; Then, when the blood flow of carotid artery has been improved after surgery, compare the cerebrovascular health of patients before surgery and the way of cerebral vascular reconstruction; Combined with the postoperative neuropsychological cognitive test to explore the postoperative cognitive recovery of patients, and combined with the postoperative imaging data and the biomarker in the blood of patients at various stages, to explore the way of cerebral vascular reconstruction and changes in brain structure and function of different groups of patients behind cognitive changes.

Being tested
magnetic resonance image, Neuropsychological scale
Keywords
Carotid Artery Stenosis, MRI Imaging
Medical subject headings
Carotid Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • magnetic resonance imageDevice

    Imaging data were collected in a strong magnetic field

  • Neuropsychological scaleDiagnostic test

    Multi dimensional neuropsychological test

Study groups in NCT05848921
Study groupRoleWhat they receive
CAS-CNCarotid Artery Stenosis with cognitive normality
Receives: Device: magnetic resonance image; Diagnostic Test: Neuropsychological scale
CAS-MCICarotid Artery Stenosis with mild cognitive impairment
Receives: Device: magnetic resonance image; Diagnostic Test: Neuropsychological scale
HCHealthy controls
Receives: Device: magnetic resonance image; Diagnostic Test: Neuropsychological scale

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of brain volume before and after treatment

    The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months]

  2. Change of cerebrovascular morphology before and after treatment

    The change of Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  3. Change of brain function connectivity before and after operation

    The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

Secondary outcomes (10)
  1. Change of serum marker concentration before and after operation

    The change of serum marker concentration is evaluated by inflammatory cytokine.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  2. Change of plasma marker concentration before and after operation

    The change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  3. Brain evaluate basic cognition before operation

    Basic cognition is evaluated by Mini-mental State Examination (MMSE) and Clinical Dementia Rating (CDR) . For MMSE , The minimum value is 0 , and the maximum value is 30. The higher scores mean a better outcome. For CDR , the results are represented by scores of 0,0.5,1,2,3, and the degree of cognitive impairment is classified as normal, suspicious, mild, moderate, and severe

    Measured: before operation

  4. Change of executive functions before and after operation evaluated by Trail-Making Test Part A

    The change of executive functions are first evaluated by Trail-Making Test Part A test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  5. Change of executive functions before and after operation evaluated by Digit Symbol Coding score

    The change of executive functions are second evaluated by Digit Symbol Coding score. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 56.53 ± 20.17. The higher scores mean a better outcome.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  6. Change of working memory before and after operation evaluated by Forward Digit Span

    The change of working memory is first evaluated by Forward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 7.75±1.47. The higher scores mean a better outcome.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  7. Change of working memory before and after operation evaluated by Backward Digit Span

    The change of working memory is second evaluated by Backward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 5.36±1.91. The higher scores mean a better outcome.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  8. Change of language function before and after operation evaluated by Language Fluency test

    The change of language function is evaluated by Language Fluency test. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 19.43±4.81. The higher scores mean a better outcome.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  9. Change of executive functions before and after operation evaluated by Clock Drawing Test

    The change of executive functions is evaluated by Backward Digit Span. The minimum value is 0 , the maximum value is 4.

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

  10. Change of executive functions before and after operation evaluated by Trail-Making Test Part B

    The change of executive functions are first evaluated by Trail-Making Test Part B test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.It is a supplement to Trail-Making Test Part A, which is optional for patients who are not familiar with the English alphabetical order

    Measured: before operation; 3-10 Days after operation; 1 month; 6-12months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2023
  2. Study start1 May 2023 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT05848921
Sponsor's protocol ID
82071993-2
Status last verified
Apr 2023
First submitted
28 Apr 2023
Last updated
8 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Carotid Artery Stenosis and Image, run by Nanjing University of Traditional Chinese Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Bo Yin, phD (0086-13857773745, 76yinbo@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of brain volume before and after treatment (time frame: before operation; 3-10 Days after operation; 1 month; 6-12months]). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in